We continue our myeloma series, transitioning our discussion from autologous stem cell transplant to maintenance therapy for myeloma.
Content:
- Why do we use revlimid (lenalidomide) maintenance?
- What about in high risk patients?
- What is the role of MRD testing?
- What about daratumumab in the maintenance setting?
This episode has been sponsored by Primum. To sign up for a free account, check out: tfoc.primum.co.
Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes
Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!
Twitter: @TheFellowOnCall
Instagram: @TheFellowOnCall
Listen in on: Apple Podcast, Spotify, and Google Podcast
The Fellow on Call: The Heme/Onc Podcast